Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
IRWD
#2738
Ironwood Pharmaceuticals, Inc. - Class A Common Stock
4.0
0
USD
+0.01%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+0.50%
Monthly Change
+9.29%
6 month change
-7.83%
Year Change
+440.54%
Previous Close
3.9
8
Open
4.0
0
Low
4.0
0
High
4.0
0
Volume
69
Markets
US Stock Market
Healthcare
Drug Manufacturers—Specialty & Generic
IRWD
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q1, 25
Q2, 25
Q3, 25
Q4, 25
Q1, 26
TTM
Cash from operating activities
19.95 M
-15.07 M
47.58 M
74.58 M
5.12 M
112.21 M
Cash from investing activities
-31 K
-2 000
-2 000
1 000
-31 K
—
Cash from financing activities
6 000
88 K
0
122 K
6 000
—
Free cash flow
19.95 M
-15.07 M
47.58 M
74.58 M
5.12 M
112.21 M
News
Here's Why Ironwood Pharmaceuticals (IRWD) is a Strong Momentum Stock
Ironwood: Linzess Buys Time, But Apraglutide's rNPV Doesn't Close The Gap (NASDAQ:IRWD)
BioCryst (BCRX) Surges 8.1%: Is This an Indication of Further Gains?
4 Defensive Stocks to Take Refuge in as Tech Sell-off Continues
Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker
5 Small Drug Stocks to Invest in Amid a Biotech Comeback
Can Linzess Continue Driving IRWD's Revenue Growth Through 2026?
IRWD's Linzess Wins FDA Nod for Expanded Pediatric Constipation Use
Ironwood Pharmaceuticals: A Contrarian Buy Opportunity (NASDAQ:IRWD)
Ironwood Pharmaceuticals, Inc: Still A Profitable Opportunity (NASDAQ:IRWD)
Ironwood Stock Down Despite Q1 Earnings and Revenue Beat
Ironwood Pharmaceuticals, Inc. (IRWD) Q1 2026 Earnings Call Transcript